PASW stock forecast, quote, news & analysis
Ping An Biomedical Co Ltd formerly Majestic Ideal Holdings Ltd is a Cayman Islands-based holding company, conducting operations through its PRC subsidiary, NewBrand... Show more
Why Ping An Biomedical (PASW) Stock Is Down -75% in the Last 30 Days
Key Takeaways
- PASW shares fell roughly 75% over the last 30 days, sliding from about $4.93 to near $1.23 amid a 1-for-40 reverse stock split and heavy volatility.
- The sharp decline was amplified by extremely thin trading, a $300 million shelf registration, and a patent agreement expected to contribute little near-term revenue.
- The company continues to face declining revenue, recurring net losses, and a Nasdaq minimum bid price compliance concern.
- The stock has also dropped approximately 76% over the last quarter, extending a much longer downtrend since its 2025 IPO.
- With a market capitalization of only a few million dollars and concentrated ownership, small order flows can produce outsized price swings in either direction.
- For deeper context on valuation, earnings, and analyst expectations, explore additional pages on Price Targets, Earnings, and Forecast.
- Investors tracking automated strategies can also explore Trending AI Robots for additional market tools.
Ping An Biomedical (PASW) Company Overview and Market Position
Ping An Biomedical Co., Ltd. is a Hong Kong-based holding company that provides supply chain management services to the apparel industry across China, Hong Kong, Cambodia, and Europe. Its offerings span market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management, organized primarily across yarn and finished garment divisions. The company also engages in textile manufacturing and trading, real estate property investment, and warehousing.
Founded in 2013 and operating as a subsidiary of Action Holdings Limited, the company previously traded as Majestic Ideal Holdings Ltd. before rebranding to Ping An Biomedical Co., Ltd. in September 2025. It completed its initial public offering in July 2025 and trades on the Nasdaq Capital Market. Investors follow the stock for its exposure to apparel supply chains and its recent pivot toward biomedical assets, though the company remains small, thinly traded, and highly concentrated in ownership.
Ping An Biomedical (PASW) Stock Price Performance: Last 30 Days vs. Quarter
Over the last 30 days, PASW shares have fallen from roughly $4.93 to about $1.23, a decline of approximately 75%. The move was not gradual: the stock compressed sharply in late October and again in early November, with several single-day drops exceeding 40% amid unusually heavy volume relative to its typical trading.
The quarterly picture is similarly negative. Measured from levels near $5.20 about three months earlier, shares have declined roughly 76%, extending a longer slide that has left the stock down more than 95% from its 52-week high. The 50-day moving average remains well above the current quote, and momentum indicators have entered oversold territory, reflecting sustained selling pressure rather than an isolated one-day event.
What Drove PASW Stock Price in the Last 30 Days
Several verified developments converged to drive the recent selloff. A 1-for-40 reverse stock split took effect on October 23, 2026, reducing outstanding shares from approximately 125.1 million to roughly 3.1 million. While reverse splits raise the quoted price without changing proportional ownership, they are frequently interpreted as a sign of financial distress and are often followed by renewed selling once supply returns to the market.
On the same date, the company filed a Form F-3 shelf registration authorizing up to $300 million in potential securities issuance, raising dilution concerns for existing shareholders. Management also disclosed a letter of intent involving three tumor-related patents valued between $2.0 million and $2.5 million, while cautioning that these patents are expected to contribute minimal near-term revenue.
These factors combined with the company's fundamental weakness — fiscal 2025 revenue fell roughly 61% year over year, accompanied by a net loss — and its thin float to accelerate the decline. With average daily trading activity that is small relative to the float and roughly 91% of voting control held by a single shareholder, even modest selling pressure translated into large percentage moves.
What Drove PASW Stock Performance Over the Last Quarter
The quarterly decline reflects a broader deterioration that predates the most recent leg down. Since its 2025 public listing, PASW has struggled with shrinking revenue, persistent losses, and limited institutional participation. A Nasdaq notification issued in late November 2025 regarding the company's failure to meet the minimum bid price requirement underscored its listing-compliance risk, with an initial compliance deadline set for May 2026.
The reverse split, shelf registration, and patent-related letter of intent formalized during the quarter added fresh supply and uncertainty overhang. Meanwhile, ownership concentration and minimal public float left the stock vulnerable to sharp repricing, as relatively few orders could move the quote by double-digit percentages. The result has been a multi-month downtrend marked by brief rebounds followed by deeper lows.
Trending AI Robots
Tickeron's Trending AI Robots page showcases a curated selection of AI-driven trading bots from a platform that offers hundreds of automated strategies trading thousands of tickers. Only the top-performing and most relevant bots are featured in this section, helping users cut through the noise. These bots vary in strategy, timeframe, and performance metrics, covering approaches from swing trading to longer-horizon trend following. Because each bot uses its own rules and risk parameters, results differ across market conditions and tickers. Investors looking to complement their own research with data-driven, rule-based signals can browse the section to compare current top performers and identify strategies that match their objectives.
PASW Stock Forecast Drivers: What Investors Should Watch Next
Going forward, investors should monitor the company's progress toward Nasdaq listing compliance and any updates on its minimum bid price status. The execution and terms of the $300 million shelf registration will be a key determinant of potential dilution, as will any future capital raises. Financial results remain central: revenue stabilization, margin improvement, and a path toward reduced losses would be important signals after a year of sharp contraction.
The commercialization of the recently optioned tumor-related patents and any shift toward biomedical revenue are additional factors to track, given the company's rebranding. Given the stock's thin trading and concentrated ownership, volatility is likely to remain elevated, and price moves may not always reflect fundamentals. No forward-looking statements here should be read as investment advice or as a prediction of future performance.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
PASW's RSI Oscillator sits in oversold zone for 4 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +8.40% 3-day Advance, the price is estimated to grow further. Considering data from situations where PASW advanced for three days, in 39 of 47 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
PASW may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PASW as a result. In 19 of 19 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for PASW turned negative on November 03, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 8 similar instances when the indicator turned negative. In 8 of the 8 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
PASW moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PASW declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for PASW entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 7 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 37 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.343) is normal, around the industry mean (1.878). P/E Ratio (-4.666) is within average values for comparable stocks, (31.507). PASW's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (3.950). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. PASW's P/S Ratio (4.409) is slightly higher than the industry average of (1.630).
The Tickeron Price Growth Rating for this company is 98 (best 1 - 100 worst), indicating slightly worse than average price growth. PASW’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PASW’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 100, placing this stock worse than average.
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry Textiles